Physician profile
Mark A Mitchell
NPI 1265552756
$4,463.91
in general payments reported to CMS, 2019-2025
24 companies · $858 in 2025
The $858 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $127 · 2021: $112 · 2022: $825 · 2023: $715 · 2024: $892 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,465.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $921.23 | 2020-2025 | Watchman Access System, Watchman Flx, Eluvia |
| Medtronic, INC. | $805.81 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $529.69 | 2019-2024 | Xact, Supera, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $392.43 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $323.28 | 2019 | |
| Biosense Webster, INC. | $291.25 | 2022-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Shockwave Medical, INC | $260.91 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.22 | 2019-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $103.49 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Medtronic Vascular, INC. | $91.96 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $85.60 | 2019 | |
| Abiomed | $69.26 | 2020-2025 | |
| Amgen INC. | $67.77 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.09 | 2019 | |
| Chiesi USA, INC. | $45.10 | 2020-2025 | Kengreal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $36.67 | 2019 | |
| Vital Connect, INC | $32.62 | 2023 | Vitalpatch Rtm |
| Cardiva Medical, INC. | $30.79 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Acist Medical Systems, INC. | $29.61 | 2025 | |
| Sanofi-Aventis U.S. LLC | $25.08 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $22.75 | 2019 | |
| Vifor Pharma, INC. | $22.63 | 2019 | |
| Cordis US Corp. | $15.69 | 2025 | Mynx Control Venous |
| E.R. Squibb & Sons, L.L.C. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.